Buerger disease

Buerger disease, also called thromboangiitis obliterans (TAO), is an inflammatory disease that most often affects small and medium-sized arteries or veins in the extremities (the arms and legs), where clots block the vessels. MeSH says it is not caused by atherosclerosis and is highly associated with tobacco smoking, and that it can lead to ischemia (poor blood supply) in the digits and limbs and to ulcers. A 2025 review says the precise cause remains unclear, that surgical and endovascular approaches are largely ineffective because of the distal distribution of the disease and poor collateral circulation, and that current therapies mainly relieve symptoms.

Also called Thromboangiitis obliterans · Buerger's disease · TAO

  • Condition
  • In this atlas

Overview

Technical summary

MeSH Thromboangiitis Obliterans (D013919, exact), whose broader descriptors are Vasculitis and Arterial Occlusive Diseases. MeSH and the review both describe it as non-atherosclerotic, while the atlas page for peripheral artery disease is filed under atherosclerosis, so this record has no subtype_of parent and links to peripheral artery disease with related_to; the atlas has no vasculitis page. The record rests on the MeSH scope note and a 2025 open-access review (PMC12420300, CC BY 4.0). The smoking link is MeSH wording (highly associated) and is not stated here as a cause or as a risk figure. The review's mechanism and experimental-therapy sections are not repeated. The evidence recorded is descriptive and comes from a vocabulary entry and one review, with no study data.

Recognition

MeSH says the disease leads to digital and limb ischemia and ulcers; a 2025 review says it leads to tissue ischemia and gangrene.

Burden

No burden claims are published.

Claims and evidence

Context People with thromboangiitis obliterans (MeSH scope note and a narrative review)

Recipient
Recipient not specified
Population
People with thromboangiitis obliterans, a non-atherosclerotic inflammatory disease of small and medium-sized arteries and veins in the extremities, as the MeSH scope note and a 2025 review describe it.
Care setting
Not stated for the MeSH note. The review discusses surgical and endovascular approaches and medical therapies in general terms.
Geography
Not stated. The sources do not name a country.
Life stage
Not stated. This record makes no statement about pregnancy, newborns or children.
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (a description of a condition).
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Thromboangiitis obliterans
Excluded
None stated
  • Description Evidence synthesis Certainty not assessed

    MeSH describes thromboangiitis obliterans as a non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities, with occlusive thrombosis and fibrosis in the vessel wall leading to digital and limb ischemia and ulcers, and says it is highly associated with tobacco smoking. A 2025 review (Frontiers in Immunology) describes a non-atherosclerotic, inflammatory vasculopathy with thrombotic occlusion of small and medium-sized vessels leading to tissue ischemia and gangrene. It says the precise pathogenesis remains unclear, that the distal distribution and poor collateral circulation render surgical and endovascular approaches largely ineffective, and that current therapies primarily alleviate symptoms.

    Applies to Recipient not specified People with thromboangiitis obliterans (MeSH scope note and a narrative review)

    Certainty method
    Not assessed
    Limitations
    A vocabulary scope note and one review article, with no study data. The review's statements about its mechanism, autoimmune features and experimental therapies are not repeated. Highly associated is MeSH wording; no rate or size of association is given, and it is not a statement of cause.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (7)
    1. Supports MeSH scope note for descriptor D013919 (Thromboangiitis Obliterans)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0021426 of descriptor D013919, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0021426

      Locator
      scopeNote.@value, sentence 1
      How it applies
      MeSH: a non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      c067c0e11dcb6cfc724f44f2c8ee5ae40e768b15a8c6fc875f6e0d4b6e801c0b
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    2. Supports MeSH scope note for descriptor D013919 (Thromboangiitis Obliterans)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0021426 of descriptor D013919, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0021426

      Locator
      scopeNote.@value, sentence 2
      How it applies
      MeSH: occlusive thrombosis and fibrosis in the vessel wall lead to digital and limb ischemia and ulcers.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      c067c0e11dcb6cfc724f44f2c8ee5ae40e768b15a8c6fc875f6e0d4b6e801c0b
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    3. Supports MeSH scope note for descriptor D013919 (Thromboangiitis Obliterans)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0021426 of descriptor D013919, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0021426

      Locator
      scopeNote.@value, sentence 3
      How it applies
      MeSH: highly associated with tobacco smoking.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      c067c0e11dcb6cfc724f44f2c8ee5ae40e768b15a8c6fc875f6e0d4b6e801c0b
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    4. Supports Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons

      Publication · Frontiers in Immunology · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used. · PMCID: PMC12420300 · PMID: 40936931 · DOI: 10.3389/fimmu.2025.1668203

      Locator
      Abstract, sentence 1
      How it applies
      The review describes a non-atherosclerotic, inflammatory vasculopathy with thrombotic occlusion of small and medium-sized vessels, leading to tissue ischemia and gangrene.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    5. Supports Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons

      Publication · Frontiers in Immunology · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used. · PMCID: PMC12420300 · PMID: 40936931 · DOI: 10.3389/fimmu.2025.1668203

      Locator
      Introduction, para 1, sentence 3
      How it applies
      The review says surgical and endovascular approaches are largely ineffective because of the distal distribution and poor collateral circulation.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    6. Background Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons

      Publication · Frontiers in Immunology · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used. · PMCID: PMC12420300 · PMID: 40936931 · DOI: 10.3389/fimmu.2025.1668203

      Locator
      Introduction, para 1, sentence 4 (first part)
      How it applies
      The review says the precise pathogenesis remains unclear.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    7. Background Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons

      Publication · Frontiers in Immunology · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Front Immunol 2025;16), fetched 2026-11-18. A review article. Used only for how the review describes thromboangiitis obliterans and the limits of current treatment; its mechanism and therapy sections are not used. · PMCID: PMC12420300 · PMID: 40936931 · DOI: 10.3389/fimmu.2025.1668203

      Locator
      Abstract, sentence 4
      How it applies
      The review says current therapies mainly relieve symptoms.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      0ea84d173ef3a7672b639fbbf8a16b93dade94623ade1ac333c5279a57dec50b
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/, content-type ccbylicense). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.

Record details

Record id
cardio:buerger-disease
Content hash
90cd830b7d2d1b3fb0f2bcf7438769cdf373781f999154c201aaf2851260e6d1